How Much Flexibility is Possible When Validating New In Vivo and In Vitro Toxicity Test Methods?

Balls M. , Blaauboer B.J. , Fentem J.H. , Bruner L. , Combes R.D. , Ekwall B. , Fielder R.J. , Guillouzo A. , Lewis R.W. , Lovell D.P. , Reinhardt C.A. , Repetto G. , Sladowski D. , Spielmann H. , & Zucco F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA 23, 129–147.

Balls M. , Blaauboer B. , Brusick D. , Frazier J. , Lamb D. , Pemberton M. , Reinhardt C. , Roberfroid M. , Rosenkranz H. , Schmid B. , Spielmann H. , Stammati A-L. , & Walum E. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA 18, 313–337.

Balls M. , & Fentem J.H. (1999). The validation and acceptance of alternatives to animal testing. Toxicology in Vitro 13, 837–846.

NIH (1997). Validation and Regulatory Acceptance of Toxicological Test Methods. A Report of the ad hoc Interagency Coordinating Committee on the Validation of Alternative Methods, 105 pp. Research Triangle Park, NC, USA: NIEHS.

Worth A.P. , & Balls M. (2002). The principles of validation and the ECVAM validation process. ATLA 30, Suppl. 2, 15–21.

Stokes W.S. , Schechtman L.M. , & Hill R.N. (2002). The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM). ATLA 30, Suppl. 2, 23–32.

Balls M. , & Karcher W. (1995). The validation of alternative test methods. ATLA 23, 884–886.

OECD (1996). Final Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Test Methods, 60 pp. Paris, France: OECD.

OECD (2001). Draft Guidance Document on the Development, Validation and Regulatory Acceptance of New and Updated Internationally Acceptable Test Methods in Hazard Assessment, Environment Directorate, 43 pp. Paris, France: OECD.

Combes R.D. (1995). Regulatory genotoxicity testing: a critical appraisal. ATLA 23, 352–379.

Zeiger E. (1995). Validation of new toxicology test systems: the paradigm of genetic toxicity tests. In Alternative Methods in Toxicology and the Life Sciences, Vol. II, The World Congress on Alternatives and Animal Use in the Life Sciences: Education, Research, Testing (ed. Goldberg A.M. , & van Zutphen L.F.M. ), pp. 425–432. New York: Mary Ann Liebert.

Balls M. , Botham P.A. , Bruner L.H. , & Spielmann H. (1995). The EC/HO international validation study on alternatives to the Draize eye irritation test. Toxicology in Vitro 9, 871–929.

Curren R.D. , Southee J.A. , Spielmann H. , Liebsch M. , Fentem J.H. , & Balls M. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA 23, 211–217.

Botham P.A. , Chamberlain M. , Barratt M.D. , Curren R.D. , Esdaile D.J. , Gardner J.R. , Gordon V.C. , Hildebrand B. , Lewis R.W. , Liebsch M. , Logemann P. , Osborne R. , Ponec M. , Régnier J-F. , Steiling W. , Walker A.P. , & Balls M. (1995). A prevalidation study on in vitro skin corrosivity testing. The report and recommendations of ECVAM workshop 6. ATLA 23, 219–255.

Bruner L.H. , Carr G.J. , Chamberlain M. , & Curren R.D. (1996). Validation of alternative methods for toxicity testing. Toxicology in Vitro 10, 479–501.

Bruner L. , Carr G. , Chamberlain M. , & Curren R. (1996). No prediction model, no validation study. ATLA 24, 139–142.

Holzhütter H-G. , & Spielmann H. (1996). The use of prediction models in toxicology: what should they predict? ATLA 24, 881–884.

Archer G. , Balls M. , Bruner L.H. , Curren R.D. , Fentem J.H. , Holzhütter H-G. , Liebsch M. , Lovell D.P. , & Southee J.A. (1997). The validation of toxicological prediction models. ATLA 25, 505–516.

Genschow E. , Scholz G. , Brown N. , Piersma A. , Brady M. , Clemann N. , Huuskonen H. , Paillard F. , Bremer S. , Becker K. , & Spielmann H. (2000). Development of prediction models for three embryotoxicity tests in an ECVAM validation study. In Vitro and Molecular Toxicology 13, 15–65.

Worth A.P. , & Balls M. (2001). The importance of the prediction model in the validation of alternative tests. ATLA 29, 135–143.

Cooper-Hannan R. , Harbell J.W. , Coecke S. , Balls M. , Bowe G. , Cervinka M. , Clothier R. , Hermann F. , Klahm L.K. , de Lange J. , Liebsch M. , & Vanparys P. (1999). The principles of Good Laboratory Practice: application to in vitro toxicological studies. The report and recommendations of ECVAM workshop 37. ATLA 27, 539–577.

Hartung T. , Balls M. , Bardouille C. , Blanck O. , Coecke S. , Gstraunthaler G. , & Lewis D. (2002). Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1. ATLA 30, 407–414.

Spielmann H. , Balls M. , Dupuis J. , Pape W.J. , Pechovitch G. , de Silva O. , Holzhütter H-G. , Clothier R. , Desolle P. , Gerberick F. , Liebsch M. , Lovell W.W. , Maurer T. , Pfannenbecker U. , Potthast J.M. , Csato M. , Sladowski D. , Steiling W. , & Brantom P. (1998). The international EU/COLIPA phototoxicity validation study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro 12, 305–327.

Fentem J.H. , Archer G.E.B. , Balls M. , Botham P.A. , Curren R.D. , Earl L.K. , Esdaile D.J. , Holzhütter H-G. , & Liebsch M. (1998). The ECVAM international validation study on tests for skin corrosivity. II. Results and evaluation by the management team. Toxicology in Vitro 12, 483–524.

Genschow E. , Spielmann H. , Scholz G. , Seller A. , Brown N. , Piersma A. , Brady M. , Clemann N. , Huuskonen H. , Paillard F. , Bremer S. , & Becker K. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. ATLA 30, 151–176.

Anon. (1998). Statement on the scientific validity of the 3T3 NRU PT test (an in vitro test for phototoxic potential). ATLA 26, 7–8.

SCCNFP (1998). Opinion on in vitro methods to assess phototoxicity in the safety evaluation of cosmetic ingredients or mixtures of ingredients adopted by the plenary session of the SCCNFP of 25 November 1998. SCCNFP/0069/98. Web site http://europa.eu.int/comm/food/fs/sc/sccp/out46_en.html (Accessed 1.6.03).

Anon. (2000). European Commission: EU Directive 2000/33/EU for the 21st Amendment of Annex V of the EU Directive 86/906/EEC for classification and labelling of hazardous chemicals: Test Guideline B-40 “skin corrosivity — in vitro method” and Test Guideline B-41 “phototoxicity — in vitro 3T3 NRU phototoxicity test”. Official Journal of the European Communities L136, 90–107.

OECD (2002). Guidelines for the Testing of Chemicals: Draft Proposal for a New Guideline 432 “In Vitro 3T3 NRU Phototoxicity Test”. Paris, France: OECD.

OECD (2002). Guidelines for the Testing of Chemicals: Draft Proposal for a New Guideline 430 “In Vitro Corrosivity Test: Rat Skin Transcutaneous Electrical Resistance (TER) Test”. Paris, France: OECD.

OECD (2002). Guidelines for the Testing of Chemicals: Draft Proposal for a New Guideline 431 “In Vitro Corrosivity Test Using Human Skin Models”. Paris, France: OECD.

Spielmann H. , & Liebsch M. (2001). Lessons learned from validation of toxicity tests: from failure to acceptance into regulatory practice. Toxicology in Vitro 5, 585–590.

OECD (1997). OECD Guidelines for the Testing of Chemicals, No. 420. Acute Oral Toxicity — Fixed Dose Procedure, 14 pp. Paris, France: OECD.

OECD (1997). OECD Guidelines for the Testing of Chemicals, No. 423. Acute Oral Toxicity — Acute Toxic Class Method, 14 pp. Paris, France: OECD.

OECD (1997). OECD Guidelines for the Testing of Chemicals, No. 425. Acute Oral Toxicity — Up-and-Down Procedure, 26 pp. Paris, France: OECD.

Kimber I. , Pichowski J.S. , Betts C.J. , Cumberbatch M. , Basketter D.A. , & Dearman R.J. (2001). Alternative approaches to the identification and characterisation of chemical allergens. Toxicology in Vitro 15, 307–312.

Anon. (2000). Opinion on the murine local lymph node assay (LLNA) adopted by the SCCNFP during the 12th plenary meeting of 3 May 2000. Web site http://www.europa.eu.int/comm/food/fs/sc/sccp/outcome_en.html (Accessed 28.5.03).

Anon. (2000). Statement on the validity of the local lymph node assay for skin sensitisation testing. ATLA 28, 366–367.

Kimber I. (2002). Reduction, refinement and replacement: putting the immune system to work. ATLA 30, 569–580.

Combes R.D. (2000). Endocrine disruptors: a critical review of and in vivo testing strategies for assessing their toxic hazard to humans. ATLA 28, 81–118.

Baker V. (2001). Endocrine disruptors: testing strategies to assess human hazard. Toxicology in Vitro 15, 413–419.

Purchase I.F. (1999). Ethical review of regulatory toxicology guidelines involving experiments on animals: the example of endocrine disruptors. Toxicological Sciences 52, 141–147.

Ashby J. (2000). Validation of in vitro and in vivo methods for assessing endocrine disrupting chemicals. Toxicological Pathology 28, 432–437.

OECD (2002). OECD conference reaches agreement on principles and criteria for the international regulatory use of testing methods. Web site http://www.oecd.org/en/document/0,en-document-524-14-no-12-27605-0,00.html (Accessed 12.6.03).

Balls M. (2003). Are animal tests inherently valid? Proceedings of the Fourth World Congress. ATLA, in press.

Anon. (2001). Communication from the Commission to the Council and the European Parliament on the implementation of the Community strategy for endocrine disruptors — a range of substances suspected of interfering with the hormone systems of humans and wildlife. COM(2001)262. Web site http://europa.eu.int/comm/environment/docum/01262_en.htm (Accessed 14.6.03).

Balls M. (1997). Defined structural and performance criteria would facilitate the validation and acceptance of alternative test procedures. ATLA 25, 483–484.

Liebsch M. , Traue D. , Barrabas C. , Spielmann H. , Uphill P. , Wilkins S. , McPherson J.P. , Wiemann C. , Kaufmann T. , Remmele M. , & Holzhütter H-G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA 28, 371–401.

Kanno J. , Onyon L. , Haseman J. , Fenner-Crisp P. , Ashby J. , & Owens W. (2001). The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environmental Health Perspectives 109, 785–794.

Kanno J. , Onyon L. , Peddada S. , Ashby J. , Jacob E. , & Owens W. (2003). The OECD program to validate the rat uterotrophic bioassay: phase 2 — coded single dose studies. Environmental Health Perspectives, in press.

Kanno J. , Onyon L. , Peddada S. , Ashby J. , Jacob E. , & Owens W. (2003). The OECD program to validate the rat uterotrophic bioassay: phase 2 — dose response studies. Environmental Health Perspectives, in press.

Ashby J. , Owens W. , & Lefevre P.A. (1993). Concept evaluation: androgen-stimulated immature intact male rats as an assay for antiandrogens. Regulatory Toxicology and Pharmacology 35, 280–285.

Ashby J. , Lefevre P.A. , Deghenghi R. , & Wallis N. (2001). Replacement of surgical castration by GnRH-inhibition of Leydig cell ablation in the male rat Hershberger antiandrogen assay. Regulatory Toxicology and Pharmacology 34, 188–203.

Spielmann H. (2001). International cooperation: an essential requirement for replacing animal toxicity tests. ATLA 29, 635–648.

van Zeller A-M. , & Combes R.D. (1999). Transgenic mouse bioassays for carcinogenicity testing: a step in the right direction? ATLA 27, 839–846.

Anon. (2001). The ILSI collaborative study: evaluation program on alternative models for carcinogenicity assessment. Toxicological Sciences 29, Suppl. 1, 1–339.